SCM
Stonepine Capital Management Portfolio holdings
AUM
$102M
1-Year Return
40.04%
This Quarter Return
-13.93%
1 Year Return
+40.04%
3 Year Return
+160.28%
5 Year Return
+195.28%
10 Year Return
–
AUM
$145M
AUM Growth
-$28.6M
(-16%)
Cap. Flow
-$2.29M
Cap. Flow
% of AUM
-1.58%
Top 10 Holdings %
Top 10 Hldgs %
75.3%
Holding
32
New
2
Increased
12
Reduced
8
Closed
7
Top Buys
Top Sells
| 1 |
Emergent Biosolutions
EBS
|
$2.36M |
| 2 |
Cumberland Pharmaceuticals
CPIX
|
$2.1M |
| 3 |
CHMA
Chiasma, Inc. Common Stock
CHMA
|
$1.56M |
| 4 |
Verastem
VSTM
|
$1.48M |
| 5 |
Matinas BioPharma
MTNB
|
$1.15M |
Sector Composition
| 1 | Healthcare | 93.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Collegium Pharmaceutical
COLL
$1.24B
| – | – |
-60,045
| Closed | -$909K |
|
27
DiaMedica Therapeutics
DMAC
$278M
| – | – |
-250,000
| Closed | -$1.14M |
|
|
28
Emergent Biosolutions
EBS
$407M
| – | – |
-46,800
| Closed | -$2.36M |
|
|
29
Verastem
VSTM
$650M
| – | – |
-41,667
| Closed | -$1.48M |
|
30
Xenon Pharmaceuticals
XENE
$2.98B
| – | – |
-98,860
| Closed | -$1M |
|
|
CHMA
31
DELISTED
Chiasma, Inc. Common Stock
CHMA
| – | – |
-300,000
| Closed | -$1.56M |
|